Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2017 16:05 ET | Source: Otonomy, Inc.

Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference

SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
May 04, 2017 16:27 ET | Source: Otonomy, Inc.

Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update

SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
April 27, 2017 16:05 ET | Source: Otonomy, Inc.

Otonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update

SAN DIEGO, April 27, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
March 02, 2017 16:18 ET | Source: Otonomy, Inc.

Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Topline data for OTO-104 Phase 3 trials in Ménière’s disease expected in 2H2017 Implemented changes to commercial organization to improve OTIPRIO® sales performance Company to host conference call...
February 28, 2017 16:05 ET | Source: Otonomy, Inc.

Otonomy to Present at Cowen and Company Health Care Conference

SAN DIEGO, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
February 24, 2017 07:30 ET | Source: Otonomy, Inc.

Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update

SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 19, 2017 07:30 ET | Source: Otonomy, Inc.

Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss

SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 09, 2017 07:30 ET | Source: Otonomy, Inc.

Otonomy Provides Corporate and Product Pipeline Update

SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
January 05, 2017 07:00 ET | Source: Otonomy, Inc.

Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa

SAN DIEGO, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
January 03, 2017 07:30 ET | Source: Otonomy, Inc.

Otonomy to Present at the J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...